Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1989 Mar;44(3):161–167. doi: 10.1136/thx.44.3.161

Muscarinic receptor subtypes: implications for lung disease.

P J Barnes 1
PMCID: PMC461745  PMID: 2650010

Full text

PDF
161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashe J. H., Yarosh C. A. Differential and selective antagonism of the slow-inhibitory postsynaptic potential and slow-excitatory postsynaptic potential by gallamine and pirenzepine in the superior cervical ganglion of the rabbit. Neuropharmacology. 1984 Nov;23(11):1321–1329. doi: 10.1016/0028-3908(84)90053-4. [DOI] [PubMed] [Google Scholar]
  2. Barnes P. J. Endogenous catecholamines and asthma. J Allergy Clin Immunol. 1986 Jun;77(6):791–795. doi: 10.1016/0091-6749(86)90375-1. [DOI] [PubMed] [Google Scholar]
  3. Barnes P. J. Endogenous catecholamines and asthma. J Allergy Clin Immunol. 1986 Jun;77(6):791–795. doi: 10.1016/0091-6749(86)90375-1. [DOI] [PubMed] [Google Scholar]
  4. Barnes P. J., Minette P., Maclagan J. Muscarinic receptor subtypes in airways. Trends Pharmacol Sci. 1988 Nov;9(11):412–416. doi: 10.1016/0165-6147(88)90069-7. [DOI] [PubMed] [Google Scholar]
  5. Barnes P. J., Nadel J. A., Roberts J. M., Basbaum C. B. Muscarinic receptors in lung and trachea: autoradiographic localization using [3H]quinuclidinyl benzilate. Eur J Pharmacol. 1982 Dec 17;86(1):103–106. doi: 10.1016/0014-2999(82)90405-8. [DOI] [PubMed] [Google Scholar]
  6. Barnes P. J. Neural control of human airways in health and disease. Am Rev Respir Dis. 1986 Dec;134(6):1289–1314. doi: 10.1164/arrd.1986.134.5.1289. [DOI] [PubMed] [Google Scholar]
  7. Barnes P. J. Neural control of human airways in health and disease. Am Rev Respir Dis. 1986 Dec;134(6):1289–1314. doi: 10.1164/arrd.1986.134.5.1289. [DOI] [PubMed] [Google Scholar]
  8. Beck K. C., Vettermann J., Flavahan N. A., Rehder K. Muscarinic M1 receptors mediate the increase in pulmonary resistance during vagus nerve stimulation in dogs. Am Rev Respir Dis. 1987 Nov;136(5):1135–1139. doi: 10.1164/ajrccm/136.5.1135. [DOI] [PubMed] [Google Scholar]
  9. Blaber L. C., Fryer A. D., Maclagan J. Neuronal muscarinic receptors attenuate vagally-induced contraction of feline bronchial smooth muscle. Br J Pharmacol. 1985 Nov;86(3):723–728. doi: 10.1111/j.1476-5381.1985.tb08951.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bloom J. W., Baumgartener-Folkerts C., Palmer J. D., Yamamura H. I., Halonen M. A muscarinic receptor subtype modulates vagally stimulated bronchial contraction. J Appl Physiol (1985) 1988 Nov;65(5):2144–2150. doi: 10.1152/jappl.1988.65.5.2144. [DOI] [PubMed] [Google Scholar]
  11. Bloom J. W., Halonen M., Lawrence L. J., Rould E., Seaver N. A., Yamamura H. I. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung. J Pharmacol Exp Ther. 1987 Jan;240(1):51–58. [PubMed] [Google Scholar]
  12. Bloom J. W., Yamamura H. I., Baumgartener C., Halonen M. A muscarinic receptor with high affinity for pirenzepine mediates vagally induced bronchoconstriction. Eur J Pharmacol. 1987 Jan 6;133(1):21–27. doi: 10.1016/0014-2999(87)90201-9. [DOI] [PubMed] [Google Scholar]
  13. Bonner T. I., Buckley N. J., Young A. C., Brann M. R. Identification of a family of muscarinic acetylcholine receptor genes. Science. 1987 Jul 31;237(4814):527–532. doi: 10.1126/science.3037705. [DOI] [PubMed] [Google Scholar]
  14. Bonner T. I., Young A. C., Brann M. R., Buckley N. J. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron. 1988 Jul;1(5):403–410. doi: 10.1016/0896-6273(88)90190-0. [DOI] [PubMed] [Google Scholar]
  15. Casale T. B., Ecklund P. Characterization of muscarinic receptor subtypes on human peripheral lung. J Appl Physiol (1985) 1988 Aug;65(2):594–600. doi: 10.1152/jappl.1988.65.2.594. [DOI] [PubMed] [Google Scholar]
  16. Cazzola M., Russo S., De Santis D., Principe P., Marmo E. Respiratory responses to pirenzepine in healthy subjects. Int J Clin Pharmacol Ther Toxicol. 1987 Feb;25(2):105–109. [PubMed] [Google Scholar]
  17. Coe C. I., Barnes P. J. Reduction of nocturnal asthma by an inhaled anticholinergic drug. Chest. 1986 Oct;90(4):485–488. doi: 10.1378/chest.90.4.485. [DOI] [PubMed] [Google Scholar]
  18. Doods H. N., Mathy M. J., Davidesko D., van Charldorp K. J., de Jonge A., van Zwieten P. A. Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors. J Pharmacol Exp Ther. 1987 Jul;242(1):257–262. [PubMed] [Google Scholar]
  19. Eglen R. M., Whiting R. L. Muscarinic receptor subtypes: a critique of the current classification and a proposal for a working nomenclature. J Auton Pharmacol. 1986 Dec;6(4):323–346. doi: 10.1111/j.1474-8673.1986.tb00661.x. [DOI] [PubMed] [Google Scholar]
  20. Faulkner D., Fryer A. D., Maclagan J. Postganglionic muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol. 1986 May;88(1):181–187. doi: 10.1111/j.1476-5381.1986.tb09485.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Fryer A. D., Maclagan J. Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol. 1984 Dec;83(4):973–978. doi: 10.1111/j.1476-5381.1984.tb16539.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Grandordy B. M., Cuss F. M., Sampson A. S., Palmer J. B., Barnes P. J. Phosphatidylinositol response to cholinergic agonists in airway smooth muscle: relationship to contraction and muscarinic receptor occupancy. J Pharmacol Exp Ther. 1986 Jul;238(1):273–279. [PubMed] [Google Scholar]
  23. Gross N. J., Barnes P. J. A short tour around the muscarinic receptor. Am Rev Respir Dis. 1988 Oct;138(4):765–767. doi: 10.1164/ajrccm/138.4.765. [DOI] [PubMed] [Google Scholar]
  24. Hammer R., Berrie C. P., Birdsall N. J., Burgen A. S., Hulme E. C. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature. 1980 Jan 3;283(5742):90–92. doi: 10.1038/283090a0. [DOI] [PubMed] [Google Scholar]
  25. Hammer R., Giachetti A. Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci. 1982 Dec 27;31(26):2991–2998. doi: 10.1016/0024-3205(82)90066-2. [DOI] [PubMed] [Google Scholar]
  26. Hammer R., Giraldo E., Schiavi G. B., Monferini E., Ladinsky H. Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat. Life Sci. 1986 May 5;38(18):1653–1662. doi: 10.1016/0024-3205(86)90409-1. [DOI] [PubMed] [Google Scholar]
  27. Hirschowitz B. I., Fong J., Molina E. Effects of pirenzepine and atropine on vagal and cholinergic gastric secretion and gastrin release and on heart rate in the dog. J Pharmacol Exp Ther. 1983 May;225(2):263–268. [PubMed] [Google Scholar]
  28. Ito Y., Yoshitomi T. Autoregulation of acetylcholine release from vagus nerve terminals through activation of muscarinic receptors in the dog trachea. Br J Pharmacol. 1988 Mar;93(3):636–646. doi: 10.1111/j.1476-5381.1988.tb10321.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kubo T., Fukuda K., Mikami A., Maeda A., Takahashi H., Mishina M., Haga T., Haga K., Ichiyama A., Kangawa K. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature. 1986 Oct 2;323(6087):411–416. doi: 10.1038/323411a0. [DOI] [PubMed] [Google Scholar]
  30. Madison J. M., Jones C. A., Tom-Moy M., Brown J. K. Affinities of pirenzepine for muscarinic cholinergic receptors in membranes isolated from bovine tracheal mucosa and smooth muscle. Am Rev Respir Dis. 1987 Mar;135(3):719–724. doi: 10.1164/arrd.1987.135.3.719. [DOI] [PubMed] [Google Scholar]
  31. Melchiorre C. Polymethylene tetramines: a new generation of selective muscarinic antagonists. Trends Pharmacol Sci. 1988 Jun;9(6):216–220. doi: 10.1016/0165-6147(88)90089-2. [DOI] [PubMed] [Google Scholar]
  32. Michel A. D., Whiting R. L. Methoctramine, a polymethylene tetraamine, differentiates three subtypes of muscarinic receptor in direct binding studies. Eur J Pharmacol. 1988 Jan 5;145(1):61–66. doi: 10.1016/0014-2999(88)90349-4. [DOI] [PubMed] [Google Scholar]
  33. Minette P. A., Barnes P. J. Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea pig airways. J Appl Physiol (1985) 1988 Jun;64(6):2532–2537. doi: 10.1152/jappl.1988.64.6.2532. [DOI] [PubMed] [Google Scholar]
  34. Mitchelson F. Muscarinic receptor differentiation. Pharmacol Ther. 1988;37(3):357–423. doi: 10.1016/0163-7258(88)90005-8. [DOI] [PubMed] [Google Scholar]
  35. Morrison J. F., Pearson S. B., Dean H. G. Parasympathetic nervous system in nocturnal asthma. Br Med J (Clin Res Ed) 1988 May 21;296(6634):1427–1429. doi: 10.1136/bmj.296.6634.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Peralta E. G., Winslow J. W., Peterson G. L., Smith D. H., Ashkenazi A., Ramachandran J., Schimerlik M. I., Capon D. J. Primary structure and biochemical properties of an M2 muscarinic receptor. Science. 1987 May 1;236(4801):600–605. doi: 10.1126/science.3107123. [DOI] [PubMed] [Google Scholar]
  37. Rhoden K. J., Meldrum L. A., Barnes P. J. Inhibition of cholinergic neurotransmission in human airways by beta 2-adrenoceptors. J Appl Physiol (1985) 1988 Aug;65(2):700–705. doi: 10.1152/jappl.1988.65.2.700. [DOI] [PubMed] [Google Scholar]
  38. Schoene R. B., Martin T. R., Charan N. B., French C. L. Timolol-induced bronchospasm in asthmatic bronchitis. JAMA. 1981 Apr 10;245(14):1460–1461. [PubMed] [Google Scholar]
  39. Sertl K., Meryn S., Graninger W., Laggner A., Schlick W., Rameis H. Acute effects of pirenzepin on bronchospasm. Int J Clin Pharmacol Ther Toxicol. 1986 Dec;24(12):655–657. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES